Regencell Bioscience Holdings Limited (RGC) Earnings History
Annual and quarterly earnings data from 2019 to 2024
Loading earnings history...
RGC EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
RGC Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export RGC earnings history in CSV or JSON format
Free sign-in required to download data
Regencell Bioscience Holdings Limited (RGC) Earnings Overview
As of May 8, 2026, Regencell Bioscience Holdings Limited (RGC) reported trailing twelve-month net income of -$5M, reflecting +26.9% year-over-year growth. The company earned $-0.35 per diluted share over the past four quarters.
Looking at the long-term picture, RGC's historical earnings data spans multiple years. The company achieved its highest annual net income of -$390,990 in fiscal 2019.
Regencell Bioscience Holdings Limited is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NUVB (-$146M net income, -325.3% margin), AEYE (-$3M net income, -7.6% margin), SIGA (-$4.04T net income, 24.6% margin), RGC has comparable earnings metrics. Compare RGC vs NUVB →
RGC Earnings vs Peers
Earnings metrics vs comparable public companies
RGC Historical Earnings Data (2019–2024)
6 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$4M | +26.7% | -$5M | $-0.01 | - | - |
| 2023 | -$6M | +20.9% | -$6M | $-0.01 | - | - |
| 2022 | -$7M | -451.2% | -$8M | $-0.01 | - | - |
| 2021 | -$1M | -65.8% | -$1M | $-0.00 | - | - |
| 2020 | $-812,371 | -107.8% | $-812,371 | $-0.00 | - | - |
| 2019 | $-390,990 | - | $-390,990 | $-0.00 | - | - |
Full RGC Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See RGC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RGC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RGC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRGC — Frequently Asked Questions
Quick answers to the most common questions about buying RGC stock.
Is RGC growing earnings?
RGC EPS is $-0.35, with earnings growth accelerating to +26.9%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-5M.
What are RGC's profit margins?
Regencell Bioscience Holdings Limited net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are RGC's earnings?
RGC earnings data spans 2019-2024. The accelerating earnings trend is +26.9% YoY. Historical data enables comparison across business cycles.